Private firm Roche Diagnostic gets FDA emergency approval for COVID-19 tests, Biomerieux in pipeline

Image
ANI General News
Last Updated : Mar 18 2020 | 4:15 PM IST

New Delhi [India], Mar 18 (ANI): Amid coronavirus fears, international private diagnostic centres are coming forward to conduct the COVID-19 tests in India.

Roche Diagnostic, a Swiss private company, has got Food and Drug Administration (FDA) emergency approval for COVID-19 tests on Tuesday from Indian regulators, officials sources told ANI.

The Swiss company has received a license to conduct the COVID-19 diagnostic tests, sources said.

"Biomerieux Diagnostics, another private company, has also approached the Drug Controller General of India (DCGI). This will take 7 days to approve as officials are making an assessment," a top official requesting anonymity informed ANI.

"Once approved, Biomerieux Diagnostics company can do both the COVID-19 confirmatory tests," said the official adding that assessment of their diagnostic kits is being done.

"We want as many people as possible to come forward for medical solutions and diagnostics services at this time," said officials.

On Tuesday, the Union Health Ministry and Indian Council Of Medical Research (ICMR) constituted the guidelines for private laboratories to conduct COVID-19 tests.

These centres would work under the domain of ICMR.

ICMR has appealed to the private players to conduct the tests free of cost.

As of now, India has 72 laboratories across the country to test the samples. Also, ICMR is going to operationalise two Rapid Testing Laboratories (high throughput system) and 49 additional testing centers by the end of this week. The Rapid Testing Laboratories have a capacity to test 1400 samples each day.

According to Dr Balram Bhargava, Secretary, Department of Health Research & Director General, ICMR, "We are having a dialogue with high-quality private labs that are accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL). This is being done to understand the modalities of increasing access to the test in the endeavor to prepare for the future."

So far about 147 confirmed positive cases of COVID19 and three deaths have been reported in India.

The World Health Organisation (WHO) has declared it a pandemic. Globally, over 167,511 confirmed COVID-19 cases and 6,606 deaths across 152 countries have been reported.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 18 2020 | 4:05 PM IST

Next Story